We report 2 cases of cutaneous hyperpigmentation with eltrombopag, a novel thrombopoietin receptor agonist.
Article InformationCorresponding Author: Inbal Braunstein, MD, 3600 Spruce St, 2 Maloney, Hospital of the University of Pennsylvania, Philadelphia, PA 19103 (firstname.lastname@example.org).
Published Online: July 24, 2013. doi:10.1001/jamadermatol.2013.5107.
Conflict of Interest Disclosures: None reported.
Additional Contributions: We are indebted to Katie Dawson, MD, and the team from GlaxoSmithKline for helpful comments.